Subclinical hypo- and hyperthryroidism are common, well-defined condit
ions that often progress to overt disease. In addition, there have bee
n concerns that the subclinical states may contribute to hyperlipidemi
a, cardiac dysfunction, and osteoporosis, The author discusses the iss
ues and outlines a rational approach to management that identifies pat
ients who will benefit from treatment.